Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹489 Cr₹566 Cr₹853 Cr₹673 Cr₹400 Cr

What is the latest Capital Work in Progress ratio of PIRAMAL PHARMA ?

The latest Capital Work in Progress ratio of PIRAMAL PHARMA is ₹489 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹489 Cr
Mar2024₹566 Cr
Mar2023₹853 Cr
Mar2022₹673 Cr
Mar2021₹400 Cr

How is Capital Work in Progress of PIRAMAL PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹489 Cr
-13.54
Mar2024 ₹566 Cr
-33.68
Mar2023 ₹853 Cr
26.71
Mar2022 ₹673 Cr
68.49
Mar2021 ₹400 Cr -

Compare Capital Work in Progress of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,472.8 Cr 3.9% -5.8% -34.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.9%

-5.8%

-34.3%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses